p53 Mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas
Data up to Jan 2025
Total Citations Per Year
Abstract
References (56)
DNA sequencing with chain-terminating inhibitors
1977 • 69,181 citations
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
1983 • 26,063 citations
A genetic model for colorectal tumorigenesis
1990 • 11,800 citations
Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia
1985 • 9,128 citations
p53 Mutations in Human Cancers
1991 • 8,133 citations
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
1990 • 3,896 citations
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
1989 • 3,707 citations
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
1992 • 3,110 citations
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
1992 • 3,092 citations
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
1990 • 2,587 citations
Thymocyte apoptosis induced by p53-dependent and independent pathways
1993 • 2,322 citations
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.
1983 • 2,011 citations
Amplification of a gene encoding a p53-associated protein in human sarcomas
1992 • 1,959 citations
p53 function and dysfunction
1992 • 1,918 citations
The p53-mdm-2 autoregulatory feedback loop.
1993 • 1,795 citations
Clinical Implications of the p53 Tumor-Suppressor Gene
1993 • 1,341 citations
mdm2 expression is induced by wild type p53 activity.
1993 • 1,286 citations
Gain of function mutations in p53
1993 • 876 citations
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
1991 • 857 citations
Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53
1992 • 735 citations
Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line.
1991 • 712 citations
Clonal expansion of p53 mutant cells is associated with brain tumour progression
1992 • 687 citations
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.
1992 • 587 citations
Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
1993 • 565 citations
p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
1993 • 535 citations
p53: At the Crossroads of Molecular Carcinogenesis and Risk Sssessment
1993 • 477 citations
Molecular Pathogenesis of Cancer of the Cervix and Its Causation by Specific Human Papillomavirus Types
1994 • 381 citations
MDM2 gene amplification in metastatic osteosarcoma.
1993 • 340 citations
Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53
1993 • 329 citations
The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.
1993 • 321 citations
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours
1992 • 313 citations
Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.
1986 • 301 citations
The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection.
1989 • 277 citations
p53 point mutation in HPV negative human cervical carcinoma cell lines.
1991 • 271 citations
It was a very good year for DNA repair
1994 • 181 citations
General primer‐mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas
1990 • 180 citations
Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
1992 • 177 citations
p53 mutations in ovarian cancer: a late event?
1991 • 151 citations
Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.
1992 • 146 citations
Polymorphism at codon 213 within the p53 gene.
1991 • 137 citations
Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53
1993 • 128 citations
Analysis of the p53 gene in human uterine carcinoma cell lines.
1991 • 105 citations
Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay
1990 • 97 citations
Mutations of p53 and human papillomavirus infection in cervical carcinoma
1993 • 91 citations
Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus.
1991 • 91 citations
p53 mutations in HPV-negative cervical carcinoma.
1994 • 84 citations
p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
1993 • 70 citations
Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas
1992 • 54 citations
Absence of Mutation in the p53 and the Retinoblastoma Susceptibility Genes in Primary Cervical Carcinomas
1993 • 46 citations
Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological Phenotypes
1992 • 45 citations
The short arm of chromosome 11 likely is involved in the regulation of the human papillomavirus type 16 early enhancer-promoter and in the suppression of the transforming activity of the viral DNA
1990 • 40 citations
Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.
1993 • 38 citations
The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.
1993 • 32 citations
Correlation between HPV Positivity and State of the p53 Gene in Cervical Carcinoma Cell Lines
1993 • 30 citations
Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies
1993 • 24 citations
Clonal p53 Mutation in Primary Cervical Cancer
1993 • 5 citations
Cited By (0)
No citing papers found in database